Prognostic impact of serum procalcitonin in non-small cell lung cancer

Autor: Akihito Kubo, Masaya Fukami, Toshio Kato, Mika Sato, Hiroyuki Tanaka, Wataru Ohashi, Satoru Ito, Toshiyuki Yonezawa, Yasutaka Kato, Etsuro Yamaguchi, Kenshi Kosaka, Shigehisa Kajikawa
Rok vydání: 2020
Předmět:
Zdroj: Tumori Journal. 107:385-391
ISSN: 2038-2529
0300-8916
DOI: 10.1177/0300891620966647
Popis: Introduction: Increased serum procalcitonin (PCT), a well-known biomarker for sepsis, has been reported in several cancer types. We aimed to investigate the prognostic impact of PCT in non-small cell lung cancer (NSCLC). Methods: Medical records of 51 consecutive patients with NSCLC (Aichi Medical University Hospital) admitted between July 2017 and July 2018 were retrospectively reviewed. The patients were divided into PCT-low (PCT < 0.1 ng/mL) and PCT-high (PCT ⩾ 0.1 ng/mL) groups, and their clinical characteristics and survival were compared. Results: In contrast to the PCT-low group (n = 24), the PCT-high group (n = 27) showed significantly worse Performance Status (PS) and overall survival (OS) (PS 0–2/3–4, 16/8 versus 12/15, p = 0.034; median OS, not reached versus 127 days, p < 0.001), irrespective of the presence of infection ( p = 0.785). Multivariate analysis showed that the disease stage (IV versus I–III) and high PCT level (⩾0.1 versus Conclusion: The results suggest that serum PCT in NSCLC was elevated regardless of the presence of infection. Higher PCT levels are associated with poor PS and shorter OS in NSCLC.
Databáze: OpenAIRE